These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 17586414

  • 1. Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome.
    Sciarretta S, Ferrucci A, Ciavarella GM, De Paolis P, Venturelli V, Tocci G, De Biase L, Rubattu S, Volpe M.
    Am J Hypertens; 2007 Jul; 20(7):784-91. PubMed ID: 17586414
    [Abstract] [Full Text] [Related]

  • 2. Reduced levels of N-terminal-proatrial natriuretic peptide in hypertensive patients with metabolic syndrome and their relationship with left ventricular mass.
    Rubattu S, Sciarretta S, Ciavarella GM, Venturelli V, De Paolis P, Tocci G, De Biase L, Ferrucci A, Volpe M.
    J Hypertens; 2007 Apr; 25(4):833-9. PubMed ID: 17351376
    [Abstract] [Full Text] [Related]

  • 3. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
    Navarro-González JF, Mora C, Muros M, Jarque A, Herrera H, García J.
    J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
    [Abstract] [Full Text] [Related]

  • 4. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients.
    Demir M, Acartürk E, Inal T, Attila G, Dönmez Y, Avkaroğullari M, Cayli M.
    Cardiovasc Pathol; 2007 Nov; 16(2):69-74. PubMed ID: 17317538
    [Abstract] [Full Text] [Related]

  • 5. Maximum oxygen uptake at peak exercise in elderly patients with coronary artery disease and preserved left ventricular function: the role of inflammation on top of tissue Doppler-derived systolic and diastolic function.
    Van de Veire NR, De Winter O, Philippé J, De Buyzere M, Bernard D, Langlois M, Gillebert TC, De Sutter J.
    Am Heart J; 2006 Aug; 152(2):297.e1-7. PubMed ID: 16875912
    [Abstract] [Full Text] [Related]

  • 6. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
    Palermo A, Mulè G, Vadalà A, Vaccaro F, Guarneri M, Arsena R, Briolotta C, Cerasola G, Cottone S.
    Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
    [Abstract] [Full Text] [Related]

  • 7. Association of adiponectin with procollagen type I carboxyterminal propeptide in non-diabetic essential hypertension.
    Tsai WC, Lin CC, Chen JY, Huang YY, Lee CH, Li WT, Weng CM, Chen JH.
    Blood Press; 2008 Apr; 17(4):233-8. PubMed ID: 18671144
    [Abstract] [Full Text] [Related]

  • 8. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure.
    Plaksej R, Kosmala W, Frantz S, Herrmann S, Niemann M, Störk S, Wachter R, Angermann CE, Ertl G, Bijnens B, Weidemann F.
    J Hypertens; 2009 Dec; 27(12):2483-91. PubMed ID: 19887955
    [Abstract] [Full Text] [Related]

  • 9. Impaired left ventricular synchronicity in patients with metabolic syndrome, regardless of hypertension.
    Li SH, Yang B, Gong HP, Tan HW, Zhong M, Zhang Y, Zhang W.
    J Hypertens; 2009 Apr; 27(4):869-75. PubMed ID: 19516184
    [Abstract] [Full Text] [Related]

  • 10. Influence of metabolic syndrome on hypertension-related target organ damage.
    Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, Mongiovì R, Mezzatesta G, Andronico G, Cerasola G.
    J Intern Med; 2005 Jun; 257(6):503-13. PubMed ID: 15910554
    [Abstract] [Full Text] [Related]

  • 11. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M, De Marco M, D'Addeo G, Benincasa M, Romano C, Galderisi M, de Simone G.
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [Abstract] [Full Text] [Related]

  • 12. [Effect of pulse wave velocity on coronary flow reserve in patients with essential hypertension].
    Wang GH, Hu DY.
    Zhonghua Yi Xue Za Zhi; 2005 Jan 05; 85(1):54-7. PubMed ID: 15808080
    [Abstract] [Full Text] [Related]

  • 13. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects.
    Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Giandalia ME, Palermo A, Mezzatesta G, Cerasola G.
    Int J Cardiol; 2007 Oct 18; 121(3):267-75. PubMed ID: 17258825
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects.
    Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Chartzoulakis G, Tousoulis D, Manolis A, Stefanadis C, Kallikazaros I.
    Am J Hypertens; 2006 May 18; 19(5):462-6. PubMed ID: 16647614
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines.
    Martell N, Alvarez-Alvarez B, Fernandez-Cruz A.
    Ther Adv Cardiovasc Dis; 2010 Apr 18; 4(2):97-103. PubMed ID: 20200202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.